Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Kelly

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Opinion in Genetics & Development|April 17, 2017
The promise of epigenetic therapy: reprogramming the cancer epigenomeAndrew D Kelly, Jean-Pierre J Issa
JCO Precision Oncology|August 23, 2021
<i>STRN-ALK</i> Fusion-Positive Case of Breast Cancer With Response to AlectinibAndrew D Kelly, Tom Wiklund, Juha Kononen, et al.
Cancer Journal (Sudbury, Mass.)|September 20, 2017
Epigenetics and Precision OncologyRachael J Werner, Andrew D Kelly, Jean-Pierre J Issa
Plos One|October 11, 2011
Metabolomic profiling from formalin-fixed, paraffin-embedded tumor tissue using targeted LC/MS/MS: application in sarcomaAndrew D Kelly, Susanne B Breitkopf, Min Yuan, et al.
Cancer Research|June 13, 2018
TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast CancerCharly Ryan Good, Shoghag Panjarian, Andrew D Kelly, et al.
Leukemia|March 21, 2018
Demethylator phenotypes in acute myeloid leukemiaAndrew D Kelly, Jozef Madzo, Priyanka Madireddi, et al.
Genomics|April 9, 2013
Next-generation sequencing and microarray-based interrogation of microRNAs from formalin-fixed, paraffin-embedded tissue: preliminary assessment of cross-platform concordanceAndrew D Kelly, Katherine E Hill, Mick Correll, et al.
Oncotarget|April 1, 2015
MicroRNA-155 expression is independently predictive of outcome in chordomaEiji Osaka, Andrew D Kelly, Dimitrios Spentzos, et al.
Journal for Immunotherapy of Cancer|November 24, 2021
Pan-cancer landscape of <i>CD274</i> (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy responseAndrew D Kelly, Karthikeyan Murugesan, Zheng Kuang, et al.
Clinical Epigenetics|July 24, 2019
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemiaWoonbok Chung, Andrew D Kelly, Patricia Kropf, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Opinion in Genetics & Development|April 17, 2017
The promise of epigenetic therapy: reprogramming the cancer epigenomeAndrew D Kelly, Jean-Pierre J Issa
JCO Precision Oncology|August 23, 2021
<i>STRN-ALK</i> Fusion-Positive Case of Breast Cancer With Response to AlectinibAndrew D Kelly, Tom Wiklund, Juha Kononen, et al.
Cancer Journal (Sudbury, Mass.)|September 20, 2017
Epigenetics and Precision OncologyRachael J Werner, Andrew D Kelly, Jean-Pierre J Issa
Plos One|October 11, 2011
Metabolomic profiling from formalin-fixed, paraffin-embedded tumor tissue using targeted LC/MS/MS: application in sarcomaAndrew D Kelly, Susanne B Breitkopf, Min Yuan, et al.
Cancer Research|June 13, 2018
TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast CancerCharly Ryan Good, Shoghag Panjarian, Andrew D Kelly, et al.
Leukemia|March 21, 2018
Demethylator phenotypes in acute myeloid leukemiaAndrew D Kelly, Jozef Madzo, Priyanka Madireddi, et al.
Genomics|April 9, 2013
Next-generation sequencing and microarray-based interrogation of microRNAs from formalin-fixed, paraffin-embedded tissue: preliminary assessment of cross-platform concordanceAndrew D Kelly, Katherine E Hill, Mick Correll, et al.
Oncotarget|April 1, 2015
MicroRNA-155 expression is independently predictive of outcome in chordomaEiji Osaka, Andrew D Kelly, Dimitrios Spentzos, et al.
Journal for Immunotherapy of Cancer|November 24, 2021
Pan-cancer landscape of <i>CD274</i> (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy responseAndrew D Kelly, Karthikeyan Murugesan, Zheng Kuang, et al.
Clinical Epigenetics|July 24, 2019
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemiaWoonbok Chung, Andrew D Kelly, Patricia Kropf, et al.
Pageof 2